Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIi pseudogene 7 (GTF2IP7) is a pseudogene of the *GTF2I* gene, which means it is a DNA sequence that closely resembles the coding gene (*GTF2I*) but is generally considered nonfunctional and does not produce a functional protein. The *GTF2I* gene itself encodes a DNA-binding transcription factor involved in regulating gene expression, but *GTF2IP7* is not known to encode protein or participate in transcriptional regulation. Pseudogenes such as GTF2IP7 can arise from gene duplication or retrotransposition, and while some pseudogenes can regulate related genes through RNA molecules, there is no evidence for such a role for GTF2IP7. The query target, GTF2IP7, is neither a validated molecular target nor a protein-coding gene; it is a non-functional pseudogene. If information on the functional *GTF2I* protein is required, please specify, as the available biomedical data and therapeutic relevance are for *GTF2I*, not its pseudogenes.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIi pseudogene 7 (GTF2IP7).